These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 15468483)
21. Medical devices. Part I. A primer on medical device regulation. Drew G FDA Consum; 1986 May; 20(4):24-7. PubMed ID: 10311540 [No Abstract] [Full Text] [Related]
22. Vioxx, radiology, and the Food and Drug Administration. Pentecost MJ J Am Coll Radiol; 2005 May; 2(5):394-7. PubMed ID: 17411841 [No Abstract] [Full Text] [Related]
23. Food and Drug Administration Modernization Act of 1997: medical device provisions. Pilot LR; Waldmann DR Food Drug Law J; 1998; 53(2):267-95. PubMed ID: 10346685 [No Abstract] [Full Text] [Related]
24. Pharmaceuticals and medical devices: business practices. End-of-year issue brief. Jones TM Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554 [No Abstract] [Full Text] [Related]
25. The development of orphan products. Finkel MJ N Engl J Med; 1982 Oct; 307(15):963-4. PubMed ID: 7110287 [No Abstract] [Full Text] [Related]
26. Industry spokesman comments on Medical Device Amendments of 1976. Lesparre M Hospitals; 1976 Sep; 50(18):99-103. PubMed ID: 964945 [No Abstract] [Full Text] [Related]
27. Medical devices--establishment of procedures to make a device a banned device: final rule. Fed Regist; 1979 May; 44(98):29213-24. PubMed ID: 10241579 [No Abstract] [Full Text] [Related]
28. Medical marketing mixture--update. DeSalvo RJ Med Mark Media; 1978 Sep; 13(9):21-2, 24, 26 passim. PubMed ID: 10238520 [No Abstract] [Full Text] [Related]
29. Medical device regulations: the Bureau of Medical Devices and the Bureau of Radiological Health. Radiol Manage; 1980; 2(4):25-38. PubMed ID: 10247745 [No Abstract] [Full Text] [Related]
30. Medical devices. Part II. The Medical Device Amendments 10 years after. Interview by William Rados. Villforth J FDA Consum; 1986 May; 20(4):28-32. PubMed ID: 10311541 [No Abstract] [Full Text] [Related]
31. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Poser S Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225 [No Abstract] [Full Text] [Related]
32. Combination products regulation at the FDA. Lauritsen KJ; Nguyen T Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151 [TBL] [Abstract][Full Text] [Related]
33. What is the Medical Device and Lab Product Problem Reporting Program? Moore R Pharm Times; 1982 Nov; 48(11):53-7. PubMed ID: 10257641 [No Abstract] [Full Text] [Related]
34. Differing definitions of manufacturer. Donawa ME Med Device Technol; 1998; 9(6):14-7. PubMed ID: 10182120 [TBL] [Abstract][Full Text] [Related]
35. Collaborations between surgeons and industry are productive and beneficial to patients. Nakayama D J Am Coll Surg; 2010 Jul; 211(1):146-7; author reply 147. PubMed ID: 20610270 [No Abstract] [Full Text] [Related]
36. [Theoretical and practical aspects of statistic sampling and related norms of acceptance]. Mattei A; Pietra E Boll Chim Farm; 1968 May; 107(5):287-95. PubMed ID: 5721540 [No Abstract] [Full Text] [Related]
37. Medical device regs: are they doing the job? Higher cost, even delayed availability, are a possibility. Smith GF AORN J; 1981 Apr; 33(5):958-60. PubMed ID: 6908514 [No Abstract] [Full Text] [Related]
38. Final FDA inspection manual. Donawa M Med Device Technol; 2001 Apr; 12(3):29-32. PubMed ID: 11547684 [TBL] [Abstract][Full Text] [Related]